MoneyWorks4Me

Valiant Laboratories - Quaterly Results

20 May 2025 Evaluate
An increase of about 88.90% to Rs. 577.70 millions in the topline was observed for the quarter ended March 2025. The topline stood at Rs. 305.83 millions during the similar quarter previous year.The Total Profit for the quarter ended March 2025 of Rs. 32.38 millions grew from Rs.-12.17 millions Operating profit Margin for the quarter ended March 2025 improved to 44.83% as compared to -20.27% of corresponding quarter ended March 2024


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 577.70 305.83 88.90 1333.62 1820.52 -26.75 1333.62 1820.52 -26.75
Other Income 6.54 25.03 -73.87 54.28 96.82 -43.94 54.28 96.82 -43.94
PBIDT 44.83 -20.27 -321.16 7.53 12.73 -40.85 7.53 12.73 -40.85
Interest 0.55 0.21 161.90 1.75 0.78 124.36 1.75 0.78 124.36
PBDT 44.28 -20.48 -316.21 5.78 11.95 -51.63 5.78 11.95 -51.63
Depreciation 5.05 5.02 0.60 20.25 19.48 3.95 20.25 19.48 3.95
PBT 39.23 -25.50 -253.84 -14.47 -7.53 92.16 -14.47 -7.53 92.16
TAX 6.85 -13.33 -151.39 7.02 -10.93 -164.23 7.02 -10.93 -164.23
Deferred Tax 6.28 2.46 155.28 6.46 -1.11 -681.98 6.46 -1.11 -681.98
PAT 32.38 -12.17 -366.06 -21.49 3.40 -732.06 -21.49 3.40 -732.06
Equity 434.50 434.50 0.00 434.50 434.50 0.00 434.50 434.50 0.00
PBIDTM(%) 7.76 -6.63 -217.08 0.56 0.70 -19.26 0.56 0.70 -19.26
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..